serum screening for Down's syndrome
Last reviewed 01/2018
Serum screening for Down's syndrome
- Screening for Down's syndrome can be undertaken from 10 weeks + 0 days to
20 weeks + 0 days of pregnancy. The recommended method of screening for Down's
syndrome is using the Combined Test
- Screening for Down's syndrome should be performed by the end of the first
trimester (14 weeks and 1 day), but provision should be made to allow later
screening (which could be as late as 20 weeks 0 days) for women booking later
in pregnancy
- Tests should meet a detection rate (DR) of more than 90%, for a screen positive
rate (SPR) of less than 2% (of affected pregnancies) for England for those
undergoing combined screening
- The following tests meet current standards:
- From 10 weeks + 0 days to 14 weeks + 1 day the combined test (maternal
serum - hCG and PAPP-A and nuchal translucency scan) is the recommended
screening strategy.
- The blood sample (or serum sample) can be taken between 10 weeks and 0 days and 14 weeks and 1 day's gestation. The blood sample uses a combination of free beta-hCG and placenta associated plasma protein A (PAPP-A).
- The NT and CRL measurement can be taken between 11 weeks and 2 days and 14 weeks and 1 days gestation o From 14 weeks + 2 days to 20 weeks + 0 days, the quadruple test (maternal serum - hCG, AFP, uE3, inhibin A)) for those presenting later is the recommended screening strategy
- From 10 weeks + 0 days to 14 weeks + 1 day the combined test (maternal
serum - hCG and PAPP-A and nuchal translucency scan) is the recommended
screening strategy.
For more information then see www.fetalanomalyscreening.nhs.uk.
Reference:
- 1. NICE. Antenatal care: routine care for the healthy pregnant woman. England: NHS National Institute for Health and Clinical Excellence; 2008 Mar. Report No.: Clinical guidelines CG62
- 2. NHS Fetal Anomaly Screening Programme. Antenatal screening - working standards for Down's syndrome screening 2007. NHS FASP; 2007.
- 3. NHS Fetal Anomaly Screening Programme. Consent standards for screening fetal anomalies during pregnancy 2007. NHS FASP; 2007.
- 4. NHS Fetal Anomaly Screening Programme. NHS fetal Anomaly screening programme - screening for Down's syndrome: UK NSC Policy recommendations 2007-2010: Model of Best Practice. Department of Health; 2008.
- 5. Kirwan D, NHS FASP. 18+0 to 20+6 weeks fetal anomaly scan -National standards and guidance for England 2010. Exeter, England: NHS Fetal Anomaly Screening Programme; 2010.
antenatal and newborn screening
Down's screening (part of the Fetal Anomaly Screening Programme)
interpretation of results from screening tests in Down's syndrome